Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

EHealth (EHTH) Q4 Loss Narrower Than Expected, View Revised

Published 03/01/2018, 11:04 PM
Updated 07/09/2023, 06:31 AM

eHealth Inc. (NASDAQ:EHTH) reported fourth-quarter 2017 adjusted net loss of 93 cents per share, narrower than the Zacks Consensus Estimate of a loss of $1.09. The figure was however, wider than the loss of 79 cents incurred a year ago.

eHealth, Inc. Price, Consensus and EPS Surprise

Revenues declined at Individual, Family and Small Business segment but improved at Medicare. Estimated memberships decreased in the period. Expenses increased as well.

Operational Update

eHealth’s total revenues amounted to $38.8 million, marginally beating the Zacks Consensus Estimate of $38 million. Also, the top line is down 11% year over year due to lower Individual, Family and Small Business revenues.

Total operating costs and expenses rose 2.7% year over year to $62.2 million.

Operating margin for the reported quarter was (51%) compared with (33%) in the year-earlier period.

Adjusted earnings before interest, tax, depreciation and amortization (EBITDA) were ($19.1) million compared with ($13.9) million a year ago.

Total estimated membership for eHealth as of Dec 31, 2017 was nearly 0.9 million, down 8% year over year. Of this, estimated Medicare membership increased 26% but individual and family plan membership declined 38%.

Full-Year Highlights

eHealth incurred adjusted net loss of 76 cents per share, comparing unfavorably with 17 cents earned in 2016.

Revenues of $172.4 million fell 7.8% from the level in 2016.

Financial Update

Cash and cash equivalents for eHealth as of Dec 31, 2017 were $40.3 million, down nearly 35% from $61.7 million at year-end 2016.

The company’s total assets as of Dec 31, 2017 were approximately $88.7 million, down from $108.8 million as of Dec 31, 2016.

As of Dec 31, 2017, total stockholders’ equity of eHealth was approximately $61.1 million compared with $77.6 million as of Dec 31, 2016.

Net cash used in operating activities was $15.5 million in 2017 compared with $4.1 million generated in 2016.

2018 Guidance

The company expects to generate revenues in the range of $217.5-$227.5 million with the Medicare Segment to record the same within $178.5-$183.5 million. The Individual, Family and Small Business Segment is projected to gross revenues in the band of $39-$44 million.

Adjusted earnings before interest, tax, depreciation and amortization (EBITDA) are anticipated in the range of $21.-$26.9 million. The Medicare segment profit is estimated within $45.5-$49.5 million whereas profit from the Individual, Family and Small Business segment is predicted between $6 million and $7 million.

The company expects non-GAAP net income per share of 92 cents to $1.18. Adjusted EBITDA is forecast between $1.13 and $1.39.

Zacks Rank

eHealth carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Performance of Other Insurance Brokers

Among other players from the insurance industry that have reported fourth-quarter earnings, the bottom line of Brown & Brown, Inc. (NYSE:BRO) , Arthur J. Gallagher & Co. (NYSE:AJG) and Marsh & McLennan Companies, Inc. (NYSE:MMC) beat the respective Zacks Consensus Estimate.

Don’t Even Think About Buying Bitcoin Until You Read This

The most popular cryptocurrency skyrocketed last year, giving some investors the chance to bank 20X returns or even more. Those gains, however, came with serious volatility and risk. Bitcoin sank 25% or more 3 times in 2017.

Zacks’ has just released a new Special Report to help readers capitalize on the explosive profit potential of Bitcoin and the other cryptocurrencies with significantly less volatility than buying them directly.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

See 4 crypto-related stocks now >>



Marsh & McLennan Companies, Inc. (MMC): Free Stock Analysis Report

Brown & Brown, Inc. (BRO): Free Stock Analysis Report

Arthur J. Gallagher & Co. (AJG): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.